To verify if STK24 mediates tumor PD‐L1 expression through an AKT activation‐dependent manner, we employed the AKT activation‐specific inhibitor MK2206 to treat Ctrl and Stk24 KO cells prior to IFN‐γ induction. The gene discussed is IFNG; the disease is neoplasm.